Evidence map›Paper›PMID 31435254›Full record

ArticleJournal of Taibah University Medical Sciences2017

Synthesis of silver nanoparticles with antimicrobial and anti-adherence activities against multidrug-resistant isolates from

Mohamed A Shaker, Mona I Shaaban

Abstract read
In one paragraph

Article in Journal of Taibah University Medical Sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Extracellular Synthesis of Bioactive Silver Nanoparticles UsingJournal of functional biomaterials · 2025
    Article
  3. Article
  4. Article
  5. Comprehensive Approaches to CombattingAntibiotics (Basel, Switzerland) · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Endophytic BacteriaPharmaceutics · 2021
    Article
  12. Silver nanoparticles-chitosan composites activity against resistant bacteria: tolerance and biofilm inhibition.Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology · 2021
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohamed A ShakerPharmaceutics and Pharmaceutical Technology Department, College of Pharmacy, Taibah University, Almadinah Almunawwarah, KSA.
Mona I ShaabanPharmaceutics and Pharmaceutical Technology Department, College of Pharmacy, Taibah University, Almadinah Almunawwarah, KSA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe spread of multidrug-resistant pathogens poses a major health threat. Silver nanoparticles represent a new-class of antimicrobial agents. The aim of this study is the microbial synthesis of silver nanoparticles and the evaluation of their antimicrobial and antibiofilm activities.

methodsSilver nanoparticles were synthesized using cell free supernatants of

resultsThe silver nanoparticle synthesis was monitored primarily by the conversion of the pale yellow colour of the bacteria free supernatants into a dark brown colour. Silver nanoparticles had uniform spherical shape, with particle sizes ranging from 37 to 168 nm and a zeta potential of -11.7 mV. Acinetobacter silver nanoparticles were effective against multidrug-resistant

conclusionSilver nanoparticles, synthesized from

Indexed as

Acinetobacter baumanniiAntibiofilmAntimicrobial activityEscherichia coliSilver nanoparticles

Identifiers

PMID31435254
PMCPMC6694881

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.